[
    [
        {
            "time": "2018-01-02",
            "original_text": "IPO Stock Returns Bullish Gains After Lilly-Partnered Covid Drug Nabs OK",
            "features": {
                "keywords": [
                    "IPO",
                    "Stock",
                    "Returns",
                    "Bullish",
                    "Gains",
                    "Lilly-Partnered",
                    "Covid",
                    "Drug",
                    "Nabs",
                    "OK"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "IPO Stock Returns Bullish Gains After Lilly-Partnered Covid Drug Nabs OK",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-10",
            "original_text": "Coronavirus update: CDC endorses double-masking as COVID vaccine push continues",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "update",
                    "CDC",
                    "double-masking",
                    "COVID",
                    "vaccine",
                    "push",
                    "continues"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "public health"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Coronavirus update: CDC endorses double-masking as COVID vaccine push continues",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-15",
            "original_text": "WHO Recommends Use of AstraZeneca Vaccine Against Variants",
            "features": {
                "keywords": [
                    "WHO",
                    "Recommends",
                    "Use",
                    "AstraZeneca",
                    "Vaccine",
                    "Against",
                    "Variants"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "WHO Recommends Use of AstraZeneca Vaccine Against Variants",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-02-09",
            "original_text": "Lilly (LLY) COVID-19 Antibody Combo Gets FDA's Emergency Nod",
            "features": {
                "keywords": [
                    "Lilly",
                    "LLY",
                    "COVID-19",
                    "Antibody",
                    "Combo",
                    "FDA",
                    "Emergency",
                    "Nod"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly (LLY) COVID-19 Antibody Combo Gets FDA's Emergency Nod",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-09-27",
            "original_text": "TikTok Sale to Oracle, Walmart Called Off Indefinitely",
            "features": {
                "keywords": [
                    "TikTok",
                    "Sale",
                    "Oracle",
                    "Walmart",
                    "Called",
                    "Off",
                    "Indefinitely"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "social media"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "TikTok Sale to Oracle, Walmart Called Off Indefinitely",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-02-10",
            "original_text": "IPO Stock AbCellera Nears Breakout After Lilly-Partnered Covid Drug Nabs OK",
            "features": {
                "keywords": [
                    "IPO",
                    "Stock",
                    "AbCellera",
                    "Nears",
                    "Breakout",
                    "Lilly-Partnered",
                    "Covid",
                    "Drug",
                    "Nabs",
                    "OK"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "IPO Stock AbCellera Nears Breakout After Lilly-Partnered Covid Drug Nabs OK",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-09",
            "original_text": "FDA grants authorization to Lilly's COVID-19 antibody treatment",
            "features": {
                "keywords": [
                    "FDA",
                    "grants",
                    "authorization",
                    "Lilly's",
                    "COVID-19",
                    "antibody",
                    "treatment"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "FDA grants authorization to Lilly's COVID-19 antibody treatment",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-12",
            "original_text": "Eli Lilly Doesn't Plan To Claw Back Past Pay From Former CFO - WSJ",
            "features": {
                "keywords": [
                    "Eli",
                    "Lilly",
                    "Doesn't",
                    "Plan",
                    "Claw",
                    "Back",
                    "Past",
                    "Pay",
                    "Former",
                    "CFO",
                    "WSJ"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "corporate governance"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Eli Lilly Doesn't Plan To Claw Back Past Pay From Former CFO - WSJ",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-02-10",
            "original_text": "The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs",
            "features": {
                "keywords": [
                    "Daily",
                    "Biotech",
                    "Pulse",
                    "Lilly",
                    "COVID-19",
                    "Antibody",
                    "Cocktail",
                    "Approved",
                    "Emergency",
                    "Use",
                    "Gamida",
                    "Genfit",
                    "Jump",
                    "Data",
                    "IPOs"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-02-09",
            "original_text": "Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval",
            "features": {
                "keywords": [
                    "Eli",
                    "Lilly",
                    "Antibody",
                    "Drug",
                    "Combo",
                    "COVID-19",
                    "Gets",
                    "FDA",
                    "Emergency",
                    "Approval"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-09",
            "original_text": "Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19",
            "features": {
                "keywords": [
                    "Etesevimab",
                    "JS016",
                    "Administered",
                    "Bamlanivimab",
                    "Receives",
                    "FDA",
                    "Emergency",
                    "Use",
                    "Authorization",
                    "COVID-19"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-09",
            "original_text": "REFILE-UPDATE 1-Eli Lilly's antibody combination receives FDA emergency use authorization for COVID-19",
            "features": {
                "keywords": [
                    "REFILE",
                    "UPDATE",
                    "Eli",
                    "Lilly",
                    "antibody",
                    "combination",
                    "receives",
                    "FDA",
                    "emergency",
                    "use",
                    "authorization",
                    "COVID-19"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "REFILE-UPDATE 1-Eli Lilly's antibody combination receives FDA emergency use authorization for COVID-19",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-09",
            "original_text": "Lilly's bamlanivimab (LY-CoV555) administered with etesevimab (LY-CoV016) receives FDA emergency use authorization for COVID-19",
            "features": {
                "keywords": [
                    "Lilly's",
                    "bamlanivimab",
                    "LY-CoV555",
                    "administered",
                    "etesevimab",
                    "LY-CoV016",
                    "receives",
                    "FDA",
                    "emergency",
                    "use",
                    "authorization",
                    "COVID-19"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly's bamlanivimab (LY-CoV555) administered with etesevimab (LY-CoV016) receives FDA emergency use authorization for COVID-19",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]